Donna L. Tempel
Directeur Général chez Seldar Pharma, Inc.
Postes actifs de Donna L. Tempel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Seldar Pharma, Inc.
 Seldar Pharma, Inc. Pharmaceuticals: MajorHealth Technology Seldar Pharma, Inc. develops and commercializes astellas for irritable bowel syndrome with diarrhea. The company is headquartered in Bridgewater, NJ. | Directeur Général | - | - |
| President | - | - |
Historique de carrière de Donna L. Tempel
Anciens postes connus de Donna L. Tempel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Drais Pharmaceuticals Inc.
 Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Directeur Général | 01/01/2008 | 01/12/2023 |
| Fondateur | 01/01/2007 | 01/12/2023 | |
| President | 01/01/2008 | 01/12/2023 | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Directeur/Membre du Conseil | - | - |
| Secrétaire Général | - | 19/03/2015 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| Yamanouchi Pharma America, Inc. | Directeur des opérations | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
AkaRx, Inc.
 AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Directeur des opérations | 01/01/2005 | - |
| Fondateur | 01/01/2005 | - | |
| Public Communications Contact | 01/01/2005 | - |
Formation de Donna L. Tempel
| Hunter College | Undergraduate Degree |
| John Jay College of Criminal Justice | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 11 |
Opérationnelle
| Chief Operating Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 5 |
|---|---|
AkaRx, Inc.
AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Health Technology |
Drais Pharmaceuticals Inc.
Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Health Technology |
| Yamanouchi Pharma America, Inc. | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Seldar Pharma, Inc.
Seldar Pharma, Inc. Pharmaceuticals: MajorHealth Technology Seldar Pharma, Inc. develops and commercializes astellas for irritable bowel syndrome with diarrhea. The company is headquartered in Bridgewater, NJ. | Health Technology |
- Bourse
- Insiders
- Donna L. Tempel
- Expérience
